Wielenga et al. [70] demonstrated that CD44 is a target gene of Wnt/β-catenin in a mice intestinal tumor model, suggesting that β-catenin signaling pathway could upregulate CD44 transcription. This evidence concerns the gene CD44 and intestinal neoplasm.